We are live on ! Find out more
ONC

BeOne Medicines Ltd

222 hedge funds and large institutions have $7.2B invested in BeOne Medicines Ltd in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 73 increasing their positions, 78 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $12.1M | Put options by funds: $2.79M

0% more funds holding in top 10

Funds holding in top 10: 99 (0)

0.02% less ownership

Funds ownership: 3.99%3.97% (-0.02%)

6% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 78

5% less funds holding

Funds holding: 234222 (-12)

17% less capital invested

Capital invested by funds: $8.65B → $7.2B (-$1.45B)

28% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 36

Holders
222
Holders Change
-12
Holders Change %
-5.13%
% of All Funds
3.82%
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.16%
New
26
Increased
73
Reduced
78
Closed
36
Calls
$12.1M
Puts
$2.79M
Net Calls
+$9.3M
Net Calls Change
+$2.34M
Name Holding Trade Value Shares
Change
Change in
Stake
BWM
251
BerganKDV Wealth Management
Minnesota
-$2K -13 Closed
AF
252
Advisornet Financial
Minnesota
-$1.37K -8 -80%
MFT
253
Moisand Fitzgerald Tamayo
Florida
-$1K -4 Closed
WFA
254
Wipfli Financial Advisors
Wisconsin
+$172 +1 New

ONC Hedge Fund Activity: Q3 2022 in Review

222 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2022, worth a combined $7.2B — down 17% from $8.65B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of ONC and 26 opened new positions — a net loss of 10 holders — while 78 trimmed existing stakes and 73 added.

The largest buyer was Primecap Management, adding an estimated $121M. The largest seller was Fidelity Investments, cutting an estimated $49.2M.

  • 222 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2022, down from 234 in Q2 2022.
  • Funds reported $7.2B of BeOne Medicines Ltd stock for Q3 2022, down 17% quarter-over-quarter.
  • 26 funds opened new BeOne Medicines Ltd positions in Q3 2022 and 36 closed out, a net change of -10 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2022 was Primecap Management, an estimated $121M added.
  • The largest BeOne Medicines Ltd seller in Q3 2022 was Fidelity Investments, an estimated $49.2M sold.

Based on aggregated 13F filings for Q3 2022.